Dimensional Fund Advisors
PCSA icon

Dimensional Fund Advisors’s Processa Pharmaceuticals PCSA Stock Holding History

Dimensional Fund Advisors’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25
Closed -$28K – 3510
2022
Q3 		$28K Buy
+25
New +$36.8K ﹤0.01% 3451

Other funds holding PCSA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's PCSA Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Processa Pharmaceuticals (PCSA) in Q4 2022, closing a stake of 25 shares — an estimated $28K sold.

Dimensional Fund Advisors first reported a position in PCSA in Q3 2022 and held it in 1 quarter. The position peaked at $28K in Q3 2022. 17 funds tracked by Wall St. Rank hold PCSA as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Processa Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 25 Processa Pharmaceuticals shares in Q4 2022, an estimated $28K.
  • Dimensional Fund Advisors first reported a position in Processa Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Dimensional Fund Advisors's Processa Pharmaceuticals position peaked at $28K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.